| __timestamp | Regeneron Pharmaceuticals, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 504755000 | 2917513 |
| Thursday, January 1, 2015 | 838526000 | 7878291 |
| Friday, January 1, 2016 | 1177697000 | 8366794 |
| Sunday, January 1, 2017 | 1320433000 | 6610381 |
| Monday, January 1, 2018 | 1556200000 | 6556000 |
| Tuesday, January 1, 2019 | 1834800000 | 6930000 |
| Wednesday, January 1, 2020 | 1346000000 | 8758000 |
| Friday, January 1, 2021 | 1824900000 | 10806000 |
| Saturday, January 1, 2022 | 2115900000 | 9844000 |
| Sunday, January 1, 2023 | 2631300000 | 13481000 |
| Monday, January 1, 2024 | 2954400000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Regeneron Pharmaceuticals, Inc. and Soleno Therapeutics, Inc. from 2014 to 2023. Regeneron, a giant in the industry, has seen its SG&A expenses grow by over 400% during this period, peaking at approximately $2.6 billion in 2023. In contrast, Soleno Therapeutics, a smaller player, has maintained a more modest increase, with expenses rising by about 360% to $13.5 million in the same year.
This stark difference highlights the scale and operational strategies of these companies. While Regeneron's expansive growth reflects its broad market reach and product development, Soleno's leaner approach may indicate a focus on niche markets or cost efficiency. Understanding these dynamics offers valuable insights into the financial strategies of biotech firms.
Eli Lilly and Company vs Regeneron Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Johnson & Johnson vs Soleno Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Mesoblast Limited Trends and Insights
Regeneron Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Soleno Therapeutics, Inc.
BioMarin Pharmaceutical Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Perrigo Company plc vs Soleno Therapeutics, Inc. Trends and Insights
ImmunityBio, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Ligand Pharmaceuticals Incorporated and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Soleno Therapeutics, Inc. vs Xencor, Inc.